Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ivo, Palásek"'
Publikováno v:
Leukemia. 23:793-796
Acute myeloid leukemia (AML) is a heterogeneous group of diseases affecting hematopoietic stem cells. In recent years, several novel molecular abnormalities have been identified in patients with AML, particularly in cases with normal karyotype. Among
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a24bd877250302417c2dfb4f997bbd1c
https://doi.org/10.1038/leu.2008.268
https://doi.org/10.1038/leu.2008.268
Autor:
Doubek M, Dana Dvorakova, Jitka Berkovcová, Ivo Palásek, Yvona Brychtová, Marta Krejčí, Jiří Mayer
Publikováno v:
Leukemia. 19:885-888
Acute myeloid leukemias with recurrent genetic abnormalities: frequent assessment of minimal residual disease and treatment of molecular relapse with chemotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d89d7d21fe4c402ccf64bff0ccd22ea
https://doi.org/10.1038/sj.leu.2403708
https://doi.org/10.1038/sj.leu.2403708
Autor:
Ivo Palásek, Zdenek Racil, Dana Dvorakova, Jiri Mayer, Ivana Jeziskova, Filip Rázga, Martina Lengerová, Markéta Protivánková
Publikováno v:
American journal of hematology. 85(12)
Nucleophosmin (NPM1) mutations in exon 12 are the most common genetic alternation in cytogenetically normal AML (CN-AML). Although mutation types A, B, and D represent the majority of cases, rare mutation variants of the NPM1 gene in individual patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91a8e2b652a7e3b5edc5bc0fc1a89b3c
https://pubmed.ncbi.nlm.nih.gov/20981679
https://pubmed.ncbi.nlm.nih.gov/20981679
Autor:
Michaela, Pevná, Petr, Vondrácek, Ivo, Palásek, Milos, Kerkovský, Zdenĕk, Korístek, Milan, Navrátil, Martin, Klabusay
Publikováno v:
Casopis lekaru ceskych. 149(4)
Toxoplasmosis is a rare opportunistic protozoal infection, which may occur in patients after hematopoietic stem cell transplantation. This disease originates almost exclusively from reactivation of latent infection in seropositive recipients. We pres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f07b08b82ba03022fea4185d65a6d78c
https://pubmed.ncbi.nlm.nih.gov/20518252
https://pubmed.ncbi.nlm.nih.gov/20518252
Autor:
Martin Klabusay, Ivo Palásek, Marta Krejčí, Marek Borsky, Ivana Jeziskova, Dana Dvorakova, Jiri Mayer, Michael Doubek, Zdenek Pospisil, Yvona Brychtová, Tomáš Jurček
Publikováno v:
Experimental hematology. 37(6)
Objective Our objective was to determine the value of frequent minimal residual disease (MRD) monitoring in acute myeloid leukemia (AML) as a robust marker of impending relapse, and whether treatment benefits patients during the MRD-positive phase of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb866945db91515421b51753d485208
https://pubmed.ncbi.nlm.nih.gov/19463768
https://pubmed.ncbi.nlm.nih.gov/19463768
Autor:
Zdenek Racil, Ivo Palásek, Martina Lengerová, Ivana Jeziskova, Jiri Mayer, Markéta Protivánková, Dana Dvorakova
Publikováno v:
Blood. 114:4672-4672
Abstract 4672 Background Mutations within NPM1 gene occurs in about 60% of adult cytogenetic normal AML (CN-AML) and represent the single most frequent molecular aberration in this subgroups of patients. These mutations usually occur at exon 12 and i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3553d8e7e408c72709a1ffe61d70aaa9
https://doi.org/10.1182/blood.v114.22.4672.4672
https://doi.org/10.1182/blood.v114.22.4672.4672
Autor:
Dana Dvorakova, Marek Borsky, Yvona Brychtová, Sona Struncova, Jiri Mayer, Michael Doubek, Martin Klabusay, Zdenek Pospisil, Ivo Palásek, Marta Krejčí
Publikováno v:
Blood. 110:4356-4356
Background. It seems that the population of leukemia stem cells (LSCs) have fundamental importance in the origin and maintenance of the acute myeloid leukaemia (AML). Eradication of LSCs is a new goal of AML therapy. We hypothesized, that by monitori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45a09d3a0ee71d94557571011525ca3e
https://doi.org/10.1182/blood.v110.11.4356.4356
https://doi.org/10.1182/blood.v110.11.4356.4356